Araştırma Makalesi

25(OH)D3 levels in children with allergic rhinoconjunctivitis

Cilt: 5 Sayı: 3 14 Ocak 2016
  • Ahmet Türkeli
  • Sevilay Aynacı
PDF İndir
EN TR

25(OH)D3 levels in children with allergic rhinoconjunctivitis

Öz

Objective: In this prospective study, we investigated the serum vitamin D levels [serum 25(OH)D3 levels] in children with allergic rhinoconjunctivitis (ARC). Methods: Sixty-one children with allergic rhinoconjunctivitis (study group) and 61 healthy children (control group) were included into the study. The children in the study group had an allergy against at least one active agent at skin-prick test; a total of 5 Symptoms Score (T5SS) was obtained for vitamin D [25(OH)D3] levels. Total eosinophil counts and total IgE measurement were performed. Results: In ARC group, median of T5SS scores was 1.00 for each of the rhinorrhea, sneezing, nasal congestion and nasal pruritis items. In ARC group, total eosinophil count and total IgE values were also higher than the control group. In ARC group, familial atopy was higher, and sunlight exposure was lower than the control group. Serum 25(OH)D3 levels of the ARC group (median: 15.80 ng/ml) were significantly lower than the control group (18.40 ng/ml). Considering the vitamin D levels being as sufficient/or deficient; it was deficient in 80.3% of the children in the study group and in 57.4% of the children in the control group. In the study group, sunlight exposure was insufficient; and familial atopy was present. In children with sufficient sunlight exposure, serum 25(OH)D3 levels were detected as higher. In children with familial atopy, total IgE and total eosinophil counts also increased. Conclusion: We concluded that vitamin D levels were lower in children with ARC. We recommend children to expose sunlight sufficiently to increase vitamin D levels; and therefore reduce the risk of allergic rhinoconjunctivitis. 

Anahtar Kelimeler

Kaynakça

  1. de Groot H, Brand PL, Fokkens WF, Berger MY. Allergic rhinoconjunctivitis in children. BMJ 2007;335(7627):985–8.
  2. Sayın İ, Cingi C, San T, Ulusoy S, Acar M. An important social problem: allergic rhinitis. J Med Updates 2013;3:91–5.
  3. Öçalan FCA, Özcan M, Öçalan R, Yılmaz YF, Ünal A. Relationship between symptoms of allergic rhinitis and their sever- ity with specific allergens and duration of allergic rhinitis. J Med Updates 2013;3:116–21.
  4. Hakansson K, Thomsen SF, Ulrik CS, Porsbjerg C, Backer V. Increase in the prevalence of rhinitis among Danish children from 1986 to 2001. Pediatr Allergy Immunol 2007;18:154–9.
  5. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368:733–43.
  6. Bener A, Ehlayel MS, Bener HZ, Hamid Q. The impact of vita- min D deficiency on asthma, allergic rhinitis and wheezing in children: an emerging public health problem. J Family Community Med 2014;21:154–61.
  7. Abuzeid WM, Akbar NA, Zacharek MA. Vitamin D and chron- ic rhinitis. Curr Opin Allergy Clin Immunol 2012;12:13–7.
  8. Dusso A, Brown A, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8–F28.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Ahmet Türkeli Bu kişi benim

Sevilay Aynacı Bu kişi benim

Yayımlanma Tarihi

14 Ocak 2016

Gönderilme Tarihi

14 Ocak 2016

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2015 Cilt: 5 Sayı: 3

Kaynak Göster

APA
Türkeli, A., & Aynacı, S. (2016). 25(OH)D3 levels in children with allergic rhinoconjunctivitis. ENT Updates, 5(3), 97-102. https://izlik.org/JA42CR96ZH
AMA
1.Türkeli A, Aynacı S. 25(OH)D3 levels in children with allergic rhinoconjunctivitis. ENT Updates. 2016;5(3):97-102. https://izlik.org/JA42CR96ZH
Chicago
Türkeli, Ahmet, ve Sevilay Aynacı. 2016. “25(OH)D3 levels in children with allergic rhinoconjunctivitis”. ENT Updates 5 (3): 97-102. https://izlik.org/JA42CR96ZH.
EndNote
Türkeli A, Aynacı S (01 Ocak 2016) 25(OH)D3 levels in children with allergic rhinoconjunctivitis. ENT Updates 5 3 97–102.
IEEE
[1]A. Türkeli ve S. Aynacı, “25(OH)D3 levels in children with allergic rhinoconjunctivitis”, ENT Updates, c. 5, sy 3, ss. 97–102, Oca. 2016, [çevrimiçi]. Erişim adresi: https://izlik.org/JA42CR96ZH
ISNAD
Türkeli, Ahmet - Aynacı, Sevilay. “25(OH)D3 levels in children with allergic rhinoconjunctivitis”. ENT Updates 5/3 (01 Ocak 2016): 97-102. https://izlik.org/JA42CR96ZH.
JAMA
1.Türkeli A, Aynacı S. 25(OH)D3 levels in children with allergic rhinoconjunctivitis. ENT Updates. 2016;5:97–102.
MLA
Türkeli, Ahmet, ve Sevilay Aynacı. “25(OH)D3 levels in children with allergic rhinoconjunctivitis”. ENT Updates, c. 5, sy 3, Ocak 2016, ss. 97-102, https://izlik.org/JA42CR96ZH.
Vancouver
1.Ahmet Türkeli, Sevilay Aynacı. 25(OH)D3 levels in children with allergic rhinoconjunctivitis. ENT Updates [Internet]. 01 Ocak 2016;5(3):97-102. Erişim adresi: https://izlik.org/JA42CR96ZH